It's been less than a year since the dreaded Ebola virus appeared on North American soil. In a matter of a few weeks, the virus went from being someone else's problem to a homeland threat. In the process, media headlines captured the attention of millions and struck fear into most of them. But Fearbola, as it was coined, was completely unnecessary. Last week, a report came out detailing exactly how the public responded to the Ebola crisis in the United States.
An Ebola vaccine provided 100 per cent protection in a field trial in hard-hit Guinea, researchers and officials said Friday
In 1934 and 1935, two polio vaccines were prematurely employed in large-scale trials with disastrous results. The vaccines, given to 17,000 children in Canada and the U.S., killed six and paralyzed a dozen others, the deaths and paralyses typically involving paralysis in the inoculated arm rather than in the legs, as was more normal. So traumatic was this experience -- to both the public and the research establishment -- that it would take another two decades before another polio vaccine would be brought to market.